Similarity exercise of a biosimilar medicines by mAbxience
CLIENT: mAbxience is a biotechnology company specialized in the research, development, and manufacture of biosimilar monoclonal antibodies. mAbxience is part of the pharmaceutical Insud Pharma Group.
More info at mAbxience.
SERVICE: From 3DforScience, we produced a cutting-edge 3D scientific animation to explain the biosimilar medicines by drug examples. As well as the molecular technology and the concept of similarity in the monoclonal antibodies.
Biosimilar medicines (or similar biological medicine) are biological medicines that contain a version of the active substance of an original biological product (reference product), for which equivalence has been demonstrated.
The similarity exercise ensures these attributes using state-of-the-art and highly sensitive analytical methods that determine the physicochemical structure and functional properties of the biosimilar, as compared to the reference medicinal product.
Equivalence with the reference product must be established using an exhaustive “comparability exercise”. This exercise aims to demonstrate that the slight physicochemical differences that exist between the two products have no significant impact on the quality, efficacy, and safety of the biosimilar. Thus, this implies that the active substance of both medicinal products is essentially the same.
As it is seen in the video, the team of 3DforScience achieved to explain these concepts in a very elegant and aesthetically pleasing way, while ensuring scientific accuracy.
3DforScience is a scientific communication company specialized in digital content for the pharma and biotech industries. Our passionate creative team works alongside an in-house scientific team to provide cutting-edge medical animations, scientific illustrations, virtual reality, etc. Our extensive experience within the field ensures all the content we produce is scientifically accurate, innovative, engaging, and pitched at the right level for the target audience.